← Open Payments lookup

JOCELYN NIEMKIEWICZ: Open Payments

NPI 1487038865 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$574 in 32 payments from 11 companies in 2025. Trend: 2023 $469 · 2024 $1,536 · 2025 $574

Food & beverage: $574
CompanyPaymentsAmount
ABBVIE INC.17$246
Takeda Pharmaceuticals U.S.A., Inc.3$79
QOL Medical, LLC2$63
Phathom Pharmaceuticals, Inc.3$28
Madrigal Pharmaceuticals1$26
Gilead Sciences, Inc.1$25
PFIZER INC.1$24
Janssen Biotech, Inc.1$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$21
Ardelyx, Inc.1$21

Products named: RINVOQ, ENTYVIO, LINZESS, Sucraid, VOQUEZNA, REZDIFFRA, XELJANZ, TREMFYA.

Industry payments across MD — which companies pay providers there.